What are the rabies post‑exposure prophylaxis guidelines for each exposure category (Category I, II, III), including vaccine and rabies immune globulin recommendations?

Rabies Post-Exposure Prophylaxis by Exposure Category

Category I Exposure: No PEP Required

No rabies biologicals are indicated for Category I exposures—only reassurance and wound care if needed. 1

Definition of Category I

• Touching or feeding animals, or licks on intact skin 1
• No penetration of skin by teeth or claws 1
• No contamination of mucous membranes with saliva 1

Management

• No vaccine or rabies immune globulin required 1
• Reassure the patient that rabies transmission requires virus introduction into bite wounds, open cuts, or mucous membranes 1

---

Category II Exposure: Vaccine Only (No RIG)

For Category II exposures, administer the 4-dose vaccine series on days 0,3,7, and 14 without rabies immune globulin. 1, 2

Definition of Category II

• Nibbling of uncovered skin 1
• Minor scratches or abrasions without bleeding 1
• Licks on broken skin (non-bleeding abrasions) 1

Immediate Wound Management

• Wash all wounds thoroughly with soap and water for 15 minutes 1, 2
• Irrigate with a virucidal agent such as povidone-iodine solution if available 1, 2

Vaccine Schedule (Immunocompetent Patients)

• Administer 1.0 mL of HDCV or PCECV intramuscularly on days 0,3,7, and 14 1, 2
• Inject in the deltoid muscle for adults and older children 1, 2
• Use the anterolateral thigh for young children 1, 2
• Never use the gluteal area—this produces inadequate antibody response and vaccine failure 1, 2

Special Populations

• Immunocompromised patients: Upgrade to the 5-dose regimen (days 0,3,7,14,28) with RIG at 20 IU/kg, even for Category II exposures 1
• Previously vaccinated persons: Only 2 doses needed (days 0 and 3), no RIG 1, 2, 3

---

Category III Exposure: Vaccine + RIG

Category III exposures require both the 4-dose vaccine series and human rabies immune globulin (20 IU/kg) infiltrated into and around all wounds on day 0. 1, 2

Definition of Category III

• Single or multiple transdermal bites or scratches 1
• Contamination of mucous membranes or broken skin with saliva (licks) 1
• Exposures to bats (any direct contact) 1
• Any penetration of skin by teeth 1

Immediate Wound Management

• Wash all wounds with soap and water for 15 minutes—this is the single most effective measure for preventing rabies 1, 2
• Irrigate with povidone-iodine solution if available 1, 2
• Assess tetanus immunization status and provide prophylaxis when indicated 1
• Consider antibiotics to prevent secondary bacterial infection 1
• Avoid suturing large wounds unless required for cosmetic reasons or high risk of bacterial infection 1

Human Rabies Immune Globulin (HRIG)

• Dose: 20 IU/kg body weight on day 0 1, 2
• Infiltrate the full calculated dose around and into all wounds if anatomically feasible 1, 2
• Any remaining volume is injected intramuscularly at a site distant from the vaccine injection 1, 2
• Never administer HRIG in the same syringe or anatomical site as the vaccine 1, 2
• Do not exceed 20 IU/kg—higher doses suppress active antibody production 1, 2
• HRIG can be given up to and including day 7 if initially missed; after day 7, omit it because vaccine-induced antibodies are presumed present 1, 2

Vaccine Schedule (Immunocompetent, Previously Unvaccinated)

• Administer 1.0 mL of HDCV or PCECV intramuscularly on days 0,3,7, and 14 1, 2
• Inject in the deltoid muscle for adults and older children 1, 2
• Use the anterolateral thigh for young children 1, 2
• Never use the gluteal area 1, 2

Special Populations

Previously Vaccinated (Immunocompetent)

• Only 2 doses of vaccine on days 0 and 3 1, 2, 3
• Do NOT give HRIG—it will inhibit the anamnestic antibody response 1, 2, 3

Immunocompromised Patients (Regardless of Prior Vaccination)

• 5-dose vaccine regimen on days 0,3,7,14, and 28 1, 2
• HRIG at 20 IU/kg on day 0, even if previously vaccinated 1, 2
• Mandatory serologic testing (RFFIT) 1–2 weeks after the final dose to confirm adequate antibody response (≥1:5 titer) 1
• Immunosuppressive conditions include corticosteroids, rituximab, HIV, chronic lymphoproliferative leukemia, and other immunosuppressive illnesses 1

---

Timing and Efficacy

• Initiate PEP as soon as possible after exposure, ideally within 24 hours 1, 2
• No absolute cutoff exists—treatment is indicated even if weeks or months have elapsed, as rabies incubation can exceed one year 1, 2
• When administered promptly and appropriately, PEP is nearly 100% effective in preventing human rabies 1, 2, 4
• No documented PEP failures have occurred in the United States when the protocol is followed correctly 1

---

Critical Pitfalls to Avoid

• Never use the gluteal area for vaccine administration—it produces inadequate immune response and vaccine failure 1, 2
• Never give HRIG to previously vaccinated immunocompetent persons—it suppresses the memory immune response 1, 2, 3
• Never exceed 20 IU/kg of HRIG—higher doses suppress active antibody production 1, 2
• Never mix HRIG with vaccine in the same syringe or inject at the same anatomical site 1, 2
• Do not give HRIG after day 7—vaccine-induced antibodies are presumed present by then 1, 2
• Do not delay treatment while waiting for animal observation results in rabies-endemic areas 1

---

Proposed Category IV (Severe Exposures)

Emerging evidence suggests that severe bites to the head, neck, face, or hands—especially multiple deep wounds in highly innervated areas—may warrant enhanced management. 5

Rationale for Category IV

• Rare PEP failures have occurred in severe bites to the head and neck 5
• Proximity to the CNS, high neural density, wound depth, and viral dose increase risk 5
• Current WHO categories do not account for these factors 5

Proposed Management

• Infiltrate the full calculated dose of HRIG (20 IU/kg) into and around all wounds, using more concentrated formulations if available 5
• Consider the 5-dose vaccine regimen (days 0,3,7,14,28) for severe head/neck exposures, even in immunocompetent patients 5
• Ensure meticulous wound infiltration with RIG—inadequate infiltration is a common error (only 56% of eligible patients receive proper wound infiltration in practice) 6

---

Schedule Flexibility and Adherence

• Delays of a few days for individual doses are unimportant and do not compromise protection 1
• Longer lapses (weeks) may require serologic testing 7–14 days after the final dose 1
• Over 1,000 persons annually in the U.S. receive only 3–4 doses instead of the full regimen, with no documented rabies cases 1
• No human rabies case in the U.S. has ever been attributed to receiving fewer than five doses when modern cell-culture vaccines are used 1